Loading market data...
markets

Eli Lilly's top dealmaker says don't be surprised to see more M&A that pushes Lilly into new areas

CNBC
Read Full Article at CNBC
Share:PostShare
Ad Slot — In-Article (728x90)

Eli Lilly's new top dealmaker explains how the company changed its approach to M&A now that it's the most valuable pharmaceutical company in the world.

This is a summary. For the full story, read the original article at CNBC.

Original source: CNBC

Ad Slot — Below Article (300x250)